Valiant Organics Limited has informed the Exchange regarding the outcome of the Board meeting held on February 13, 2026.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 5.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Organics' Board approved its Q3 FY26 (Dec 2025) unaudited results. Standalone revenue from operations fell to ₹15,907 lakhs from ₹18,686 lakhs in Q3 FY25, a drop of about 15% year-on-year. Despite lower revenue, standalone net profit rose to ₹606 lakhs (₹2.16 EPS) from ₹465 lakhs (₹1.18 EPS) a year ago, aided by lower input and finance costs. For the nine-month period, the company swung to a profit of ₹1,924 lakhs (₹6.87 EPS) versus a loss of ₹695 lakhs last year. Results include a one-time exceptional gain of ₹572 lakhs from a fire insurance claim related to the FY23 Sarigam division incident. The review auditor (Gokhale & Sathe) issued an unmodified limited review report on both standalone and consolidated results.
Margins improved and the company returned to profit on a nine-month basis, but top-line weakness in Q3 may concern investors. The exceptional insurance gain is non-recurring, so underlying performance remains mixed — likely a neutral-to-slightly-positive short-term reaction.